Access tomorrow's treatments today.
Connecting patients and physicians to advanced therapeutic options through clinical research.
Every patient has the right to access the best treatments available.
This is why we bring our trials to patients in their own communities. Our approach ensures that patients have access to cutting edge treatments via clinical research, with the convenience of receiving care from their trusted healthcare providers.
Patients should be at the center of everything.
We are committed to delivering compassionate care that is designed to meet the unique needs of each person. Profound enables patients to change the course of their health journey and regain control of their wellbeing.
Everyone can contribute to a better future.
By participating in clinical trials, patients can make a real difference in the lives of others facing similar health challenges. We are a community of doctors and patients committed to advancing medical science and discovering new treatments to help people live longer, healthier lives.
700+ PHYSICIANS
750,000 PATIENT PANEL
3 U.S. GEOGRAPHIES
Therapeutic Areas
Select a therapeutic area below to explore sites:
CONTACT US
A new day for clinical trials
INTEGRATED SITE OPERATIONS
FAST ACTIVATION
RELIABLE ENROLLMENT
ENHANCED STUDY CONDUCT
Our Leadership Team
Lora Parahovnik
Chief Executive Officer
Gregory Sahagian, MD
Chief Scientific Officer
Marty F. Anderson
Chief Operations Officer
David Lamadrid
Chief Financial Officer
Christopher Church
Chief Commercial Officer
Peter Kaufman
Associate General Counsel
Nicole Bielakowski
SVP, Central Operations
Sara Schmidt
Head of Quality
Iyassu Berhanu
Co-Founder
Jonathan Feldstein, MD
President, Co-Founder
David M. Glaccum
Co-Founder
Courtney C. Miller
SVP, People
Our Values
Compassion
Honor the patient-physician relationship above all else.
Efficiency
Accountable for outcomes and strive for process perfection.
Progress
Contribute to continued innovation in medicine while improving health outcomes.
Integrity
Hold ourselves to the highest ethical, quality, and scientific standards in every activity.
Latest News
At Profound Research, we're committed to highlighting the individuals who are advancing medical science and patient care through their work in clinical research. Today, we're excited to share insights from Dr. Barry Feldman, an …
Skin Biopsy as a Potential Diagnostic Tool for Synucleinopathies Exploring Promising Avenues in Neurological Research The groundwork for a notable advancement in establishing new diagnostic procedures for Synucleinopathies through skin biopsy has been laid by …
At Profound Research, we're committed to highlighting the individuals who are advancing medical science and patient care through their work in clinical research. Today, we're excited to share insights from Paul Lizotte, an Internal …
